Approval · Notice of Compliance 38101 · 2026
LEFLUNOMIDE: Notice of Compliance 38101
Issued August 13, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38101
- Date
- August 13, 2026
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Administrative: Update to labelling (to match Licensor)
- Canadian reference product
- ARAVA (Aventis Pharma Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LEFLUNOMIDE | Not yet assigned | — |
Medicinal ingredients
- LEFLUNOMIDE 10 MG per TAB
- LEFLUNOMIDE 20 MG per TAB